824 related articles for article (PubMed ID: 32988361)
1. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
2. Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia.
Chauhan MK; Sharma PK
Chem Phys Lipids; 2019 Nov; 224():104794. PubMed ID: 31361985
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
5. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
7. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
Sharma A; Singh AP; Harikumar SL
Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
[No Abstract] [Full Text] [Related]
8. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
9.
Krishna VM; Kumar VB; Dudhipala N
Pharm Nanotechnol; 2020; 8(3):207-224. PubMed ID: 32416685
[TBL] [Abstract][Full Text] [Related]
10. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
11. Development of carvedilol-loaded lipid nanoparticles with compatible lipids and enhanced skin permeation in different skin models.
Esteves NLS; Andrade LM; Krawczyk-Santos AP; Souza BDS; Marreto RN; Taveira SF
J Microencapsul; 2021 Mar; 38(2):124-133. PubMed ID: 33305646
[TBL] [Abstract][Full Text] [Related]
12. Dry Gel Containing Optimized Felodipine-Loaded Transferosomes: a Promising Transdermal Delivery System to Enhance Drug Bioavailability.
Kassem MA; Aboul-Einien MH; El Taweel MM
AAPS PharmSciTech; 2018 Jul; 19(5):2155-2173. PubMed ID: 29714001
[TBL] [Abstract][Full Text] [Related]
13. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
Gadhave DG; Tagalpallewar AA; Kokare CR
AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of bioavailability through transdermal drug delivery of paliperidone palmitate-loaded nanostructured lipid carriers.
Raval S; Jani P; Patil P; Thakkar P; Sawant K
Ther Deliv; 2021 Aug; 12(8):583-596. PubMed ID: 34286598
[No Abstract] [Full Text] [Related]
15. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats.
Zakarial Ansar FH; Latifah SY; Wan Kamal WHB; Khong KC; Ng Y; Foong JN; Gopalsamy B; Ng WK; How CW; Ong YS; Abdullah R; Aziz MY
Int J Nanomedicine; 2020; 15():7703-7717. PubMed ID: 33116496
[TBL] [Abstract][Full Text] [Related]
17. Nanotransethosomes for enhanced transdermal delivery of mangiferin against rheumatoid arthritis: formulation, characterization, invivo pharmacokinetic and pharmacodynamic evaluation.
Adin SN; Gupta I; Rashid MA; Alhamhoom Y; Aqil M; Mujeeb M
Drug Deliv; 2023 Dec; 30(1):2173338. PubMed ID: 36729134
[TBL] [Abstract][Full Text] [Related]
18. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
Zhao X; Sun Y; Li Z
Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development.
Nagaich U; Gulati N
Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874
[TBL] [Abstract][Full Text] [Related]
20. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application.
Mahmood S; Taher M; Mandal UK
Int J Nanomedicine; 2014; 9():4331-46. PubMed ID: 25246789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]